EPHA2 Antibody
Produktgrößen
50 ul
£186,00
CSB-PA179150-50UL
100 ul
£334,00
CSB-PA179150-100UL
Über dieses Produkt
- SKU:
- CSB-PA179150
- Zusätzliche Namen:
- ARCC2 antibody; AW545284 antibody; CTPA antibody; CTPP1 antibody; CTRCT6 antibody; EC 2.7.10.1 antibody; Eck antibody; Eph receptor A2 antibody; EPHA2 antibody; EPHA2_HUMAN antibody; Ephrin receptor antibody; Ephrin receptor EphA2 antibody; Ephrin type A receptor 2 antibody; Ephrin type-A receptor 2 antibody; Epithelial cell kinase antibody; Epithelial cell receptor protein tyrosine kinase antibody; Myk 2 antibody; Myk2 antibody; Sek 2 antibody; Sek2 antibody; Soluble EPHA2 variant 1 antibody; Tyrosine protein kinase receptor ECK antibody; Tyrosine-protein kinase receptor ECK antibody; Tyrosine-protein kinase receptor MPK-5 antibody; Tyrosine-protein kinase receptor SEK-2 antibody
- Anwendung:
- ELISA, Immunohistochemistry
- Buffer:
- PBS
- Klonalität:
- Polyclonal
- Weitere Details:
- This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands. Mutations in this gene are the cause of certain genetically-related cataract disorders.
- Host:
- Rabbit
- Immunogen:
- Synthetic peptide of Human EPHA2
- Isotyp:
- IgG
- Physischer Zustand:
- Liquid
- Aufreinigung:
- Affinity Purified
- Reaktivitäten:
- Human, Mouse
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- -20[o]C/-70[o]C Avoid freeze/thaw cycles.
- Hersteller:
- Cusabio
- Typ:
- Antibody: Polyclonal Antibody
- Datenblatt des Herstellers:EPHA2-Antibody-11102891.html
